These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Dysplasia and cancer in inflammatory bowel disease 10 years after diagnosis: results of a population-based European collaborative follow-up study. Katsanos KH; Vermeire S; Christodoulou DK; Riis L; Wolters F; Odes S; Freitas J; Hoie O; Beltrami M; Fornaciari G; Clofent J; Bodini P; Vatn M; Nunes PB; Moum B; Munkholm P; Limonard C; Stockbrugger R; Rutgeerts P; Tsianos EV; Digestion; 2007; 75(2-3):113-21. PubMed ID: 17598963 [TBL] [Abstract][Full Text] [Related]
5. CARD15 mutations in Dutch familial and sporadic inflammatory bowel disease and an overview of European studies. van der Linde K; Boor PP; Houwing-Duistermaat JJ; Crusius BJ; Wilson PJ; Kuipers EJ; de Rooij FW Eur J Gastroenterol Hepatol; 2007 Jun; 19(6):449-59. PubMed ID: 17489054 [TBL] [Abstract][Full Text] [Related]
6. Dietary habits as risk factors for inflammatory bowel disease. Tragnone A; Valpiani D; Miglio F; Elmi G; Bazzocchi G; Pipitone E; Lanfranchi GA Eur J Gastroenterol Hepatol; 1995 Jan; 7(1):47-51. PubMed ID: 7866810 [TBL] [Abstract][Full Text] [Related]
7. Preillness non dietary factors and habits in inflammatory bowel disease. Klein I; Reif S; Farbstein H; Halak A; Gilat T Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):247-51. PubMed ID: 9759588 [TBL] [Abstract][Full Text] [Related]
8. Assessment of the influence of disease activity on the quality of life of patients with inflammatory bowel disease using a short questionnaire. Casellas F; Alcalá MJ; Prieto L; Miró JR; Malagelada JR Am J Gastroenterol; 2004 Mar; 99(3):457-61. PubMed ID: 15056085 [TBL] [Abstract][Full Text] [Related]
9. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study. Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B; Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104 [TBL] [Abstract][Full Text] [Related]
10. Finnish patients with inflammatory bowel disease have fewer symptoms and are more satisfied with their treatment than patients in the previous European survey. Haapamäki J; Turunen U; Roine RP; Färkkilä MA; Arkkila PE Scand J Gastroenterol; 2008; 43(7):821-30. PubMed ID: 18584521 [TBL] [Abstract][Full Text] [Related]
11. Autoimmune disorders in patients affected by celiac sprue and inflammatory bowel disease. Bardella MT; Elli L; De Matteis S; Floriani I; Torri V; Piodi L Ann Med; 2009; 41(2):139-43. PubMed ID: 18777226 [TBL] [Abstract][Full Text] [Related]
12. Prevalence of inflammatory bowel disease in patients with airways disease. Raj AA; Birring SS; Green R; Grant A; de Caestecker J; Pavord ID Respir Med; 2008 May; 102(5):780-5. PubMed ID: 18321696 [TBL] [Abstract][Full Text] [Related]
13. Paediatric inflammatory bowel disease in New Zealand. Yap J; Wesley A; Mouat S; Chin S N Z Med J; 2008 Oct; 121(1283):19-34. PubMed ID: 18841182 [TBL] [Abstract][Full Text] [Related]
14. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU). Mehdizadeh S; Chen G; Enayati PJ; Cheng DW; Han NJ; Shaye OA; Ippoliti A; Vasiliauskas EA; Lo SK; Papadakis KA Endoscopy; 2008 Jan; 40(1):30-5. PubMed ID: 18058654 [TBL] [Abstract][Full Text] [Related]
15. The relationship of inflammatory bowel disease type and activity to psychological functioning and quality of life. Graff LA; Walker JR; Lix L; Clara I; Rawsthorne P; Rogala L; Miller N; Jakul L; McPhail C; Ediger J; Bernstein CN Clin Gastroenterol Hepatol; 2006 Dec; 4(12):1491-1501. PubMed ID: 17162241 [TBL] [Abstract][Full Text] [Related]
16. The association of MYO9B gene in Italian patients with inflammatory bowel diseases. Latiano A; Palmieri O; Valvano MR; D'Incà R; Caprilli R; Cucchiara S; Sturniolo GC; Bossa F; Andriulli A; Annese V Aliment Pharmacol Ther; 2008 Feb; 27(3):241-8. PubMed ID: 17944996 [TBL] [Abstract][Full Text] [Related]
17. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease. Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187 [TBL] [Abstract][Full Text] [Related]
18. Interleukin-18 and its binding protein in patients with inflammatory bowel disease during remission and exacerbation. Naftali T; Novick D; Gabay G; Rubinstein M; Novis B Isr Med Assoc J; 2007 Jul; 9(7):504-8. PubMed ID: 17710779 [TBL] [Abstract][Full Text] [Related]
19. Efficacy and tolerability of oral iron therapy in inflammatory bowel disease: a prospective, comparative trial. de Silva AD; Tsironi E; Feakins RM; Rampton DS Aliment Pharmacol Ther; 2005 Dec; 22(11-12):1097-105. PubMed ID: 16305723 [TBL] [Abstract][Full Text] [Related]
20. Pulmonary manifestations of inflammatory bowel disease. Sostegni R; Daperno M; Pera A Dig Liver Dis; 2007 Mar; 39(3):239-41. PubMed ID: 17267308 [No Abstract] [Full Text] [Related] [Next] [New Search]